Abstract:BackgroundLarge-scale genetic screening using CRISPR-Cas9 technology has emerged as a powerful approach to uncover and validate gene functions. The ability to control the timing of genetic perturbation during CRISPR screens will facilitate precise dissection of dynamic and complex biological processes. Here, we report the optimization of a drug-inducible CRISPR-Cas9 system that allows high-throughput gene interrogation with a temporal control.ResultsWe designed multiple drug-inducible sgRNA expression vectors and measured their activities using an EGFP gene disruption assay in 11 human and mouse cell lines. The optimal design allows for a tight and inducible control of gene knockout in vitro, and in vivo during a seven-week-long experiment following hematopoietic reconstitution in mice. We next performed parallel genome-wide loss-of-function screens using the inducible and constitutive CRISPR-Cas9 systems. In proliferation-based dropout screens, these two approaches have similar performance in discriminating essential and nonessential genes. In a more challenging phenotypic assay that requires cytokine stimulation and cell staining, we observed similar sensitivity of the constitutive and drug-induced screening approaches in detecting known hits. Importantly, we demonstrate minimal leakiness of our inducible CRISPR screening platforms in the absence of chemical inducers in large-scale settings.ConclusionsIn this study, we have developed a drug-inducible CRISPR-Cas9 system that shows high cleavage efficiency upon induction but low background activity. Using this system, we have achieved inducible gene disruption in a wide range of cell types both in vitro and in vivo. For the first time, we present a systematic side-by-side comparison of constitutive and drug-inducible CRISPR-Cas9 platforms in large-scale functional screens. We demonstrate the tightness and efficiency of our drug-inducible CRISPR-Cas9 system in genome-wide pooled screening. Our design increases the versatility of CRISPR-based genetic screening and represents a significant upgrade on existing functional genomics toolbox.

Unlocking biological mechanisms with integrative functional genomics approaches

Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges

Massively Parallel CRISPR‐Based Genetic Perturbation Screening at Single‐Cell Resolution

Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants

In vivo functional screening for systems-level integrative cancer genomics

Pooled Genome-Scale CRISPR Screens in Single Cells

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Exploiting Single-Cell Tools in Gene and Cell Therapy

Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System

[High-throughput functional screening using CRISPR/Cas9 system].

High-resolution characterization of gene function using single-cell CRISPR tiling screen

Genome-Wide CRISPR/Cas9 Screening for High-Throughput Functional Genomics in Human Cells

CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons

High-content CRISPR screening

Genetic Screens in Human Cells Using the CRISPR-Cas9 System

Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening

Gene Silencing Through CRISPR Interference in Bacteria: Current Advances and Future Prospects

High-Throughput Screens in Mammalian Cells Using the Crispr-Cas9 System

CRISPRi functional genomics in bacteria and its application to medical and industrial research

Progress and Application of CRISPR/Cas Technology in Biological and Biomedical Investigation.

CRISPRi with barcoded expression reporters dissects regulatory networks in human cells